跳至主要内容
临床试验/NL-OMON24989
NL-OMON24989招募中不适用

Shared decision making in patients with Castration-Resistant Prostate Cancer - The impact of implementation of a treatment decision aid in CRPC patients

Elisabeth- TweeSteden ZiekenhuisPostbus 901515000 LC Tilburg0 个研究点目标入组 168 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Men that are newly diagnosed with CRPC. CRPC is defined as any cancer progression under maximal hormonal treatment with anti-androgens and/or LHRH agonist or antagonist (when three consecutive rises of PSA are observed at castrate serum levels of testosterone (< 50 ng/dL or <1.7 nmol/L) and/or progression of osseous lesions is shown))
  • - Patients are eligible for at least two treatment options

排除标准

  • - In the case of a second opinion the patient will not be included if the first opinion was obtained in one of the other involved hospitals and vice versa
  • - Patients who do not have sufficient knowledge of the Dutch language

研究者

发起方
Elisabeth- TweeSteden ZiekenhuisPostbus 901515000 LC Tilburg

相似试验